| Maple Knoll Village | |
| 11100 Springfield Pike, Cincinnati, Ohio 45246 | |
| (513) 782-2788 | |
| Name | Maple Knoll Village |
|---|---|
| Location | 11100 Springfield Pike, Cincinnati, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 141 |
| Occupancy Rate | 62.62% |
| Medicare ID (CCN) | 365350 |
| Legal Business Name | Maple Knoll Communities, Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1194726588 |
| Organization Name | MAPLE KNOLL COMMUNITIES INC |
| Doing Business As | MAPLE KNOLL VILLAGE |
| Address | 11100 Springfield Pike, Cincinnati, OH 45246 |
| Phone Number | 513-782-2400 |
News Archive
An initiative that combines a multidisciplinary health care approach with a range of preventive measures could cut the rate of a common airway infection among children in intensive care by more than half, a new study suggests.
Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.
Knee joint injuries, such as ligament rupture, are common in athletes. As the intact joint ligaments offer a precondition for joint stability, ligament injuries are often surgically reconstructed. However, in many cases these injuries or surgeries can lead to post-traumatic osteoarthritis.
Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
An initiative that combines a multidisciplinary health care approach with a range of preventive measures could cut the rate of a common airway infection among children in intensive care by more than half, a new study suggests.
Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.
Knee joint injuries, such as ligament rupture, are common in athletes. As the intact joint ligaments offer a precondition for joint stability, ligament injuries are often surgically reconstructed. However, in many cases these injuries or surgeries can lead to post-traumatic osteoarthritis.
Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.79 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.43 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 44.16 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.15 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.35 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 11.61 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.11 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.49 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.36 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.26 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.26 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 44.12 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.9 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.61 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.03 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 47.4 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.68 | 82.93 |
News Archive
An initiative that combines a multidisciplinary health care approach with a range of preventive measures could cut the rate of a common airway infection among children in intensive care by more than half, a new study suggests.
Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.
Knee joint injuries, such as ligament rupture, are common in athletes. As the intact joint ligaments offer a precondition for joint stability, ligament injuries are often surgically reconstructed. However, in many cases these injuries or surgeries can lead to post-traumatic osteoarthritis.
Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
› Verified 9 days ago
The Chateau At Mountain Crest Nursing & Rehab Ctr Location: 2586 Lafeuille Avenue, Cincinnati, Ohio 45211 Phone: (513) 662-2444 | |
Hillebrand Nursing And Rehabilitation Center Location: 4320 Bridgetown Road, Cincinnati, Ohio 45211 Phone: (513) 574-4550 | |
Harrison Pavilion Care Center Location: 2171 Harrison Avenue, Cincinnati, Ohio 45211 Phone: (513) 662-5800 | |
Three Rivers Healthcare Center Location: 7800 Jandaracres Drive, Cincinnati, Ohio 45248 Phone: (513) 941-0787 | |